• 1
    Bresalier R. Barrett's metaplasia: defining the problem. Semin Oncol. 2005; 32: 2124.
  • 2
    Daly JM,Karnell LH,Menck HR. National cancer data base report on esophageal carcinoma. Cancer. 1996; 78: 18201828.
  • 3
    Bytzer P,Christensen PB,Damkier P,Vinding K,Seersholm N. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol. 1999; 94: 8691.
    Direct Link:
  • 4
    Devesa SS,Blot WJ,Fraumeni JFJr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998; 83: 20492053.
  • 5
    Weston AP,Badr AS,Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol. 1999; 94: 34133419.
    Direct Link:
  • 6
    Sharma P,Falk G,Weston A,Reker D,Johnston M,Sampliner R. Natural history of low-grade dysplasia, an infrequent finding which usually regresses: preliminary results from the Barrett's Esophagus Study. Gastroenterology. 2002; 122: 156.
  • 7
    Sharma P,Falk GW,Weston AP,Reker D,Johnston M,Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006; 4: 566572.
  • 8
    Eloubeidi MA,Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans. J Clin Gastroenterol. 2001; 33: 306309.
  • 9
    Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus. 2002; 15: 106108.
  • 10
    Conio M,Filiberti R,Blanchi S, et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer. 2002; 97: 225229.
  • 11
    Wakelin DE,Al-Mutawa T,Wendel C,Green C,Garewal HS,Fass R. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc. 2003; 58: 350355.
  • 12
    Williamson WA,Ellis FHJr,Gibb SP, et al. Barrett's esophagus. prevalence and incidence of adenocarcinoma. Arch Intern Med. 1991; 151: 22122216.
  • 13
    Avidan B,Sonnenberg A,Schnell TG,Chejfec G,Metz A,Sontag SJ. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol. 2002; 97: 19301936.
    Direct Link:
  • 14
    Bani-Hani KE,Bani-Hani BK,Martin IG. Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol. 2005; 11: 68076814.
  • 15
    Ronkainen J,Aro P,Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005; 129: 18251831.
  • 16
    Weston AP,Sharma P,Mathur S, et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004; 99: 16571666.
    Direct Link:
  • 17
    Iftikhar SY,James PD,Steele RJ,Hardcastle JD,Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut. 1992; 33: 11551158.
  • 18
    Yagi K,Nakamura A,Sekine A,Tamiya Y,Oyamatsu M,Watanabe H. Endoscopic findings of adenocarcinoma arising from short-segment Barrett's esophagus. J Gastroenterol Hepatol. 2004; 19: 940943.
  • 19
    Weston AP,Krmpotich PT,Cherian R,Dixon A,Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol. 1997; 92: 407413.
  • 20
    Locke GR3rd,Talley NJ,Fett SL,Zinsmeister AR,Melton LJ3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997; 112: 14481456.
  • 21
    Cameron AJ,Romero Y. Symptomatic gastro-oesophageal reflux as a risk factor for oesophageal adenocarcinoma. Gut. 2000; 46: 754755.
  • 22
    Skacel M,Petras RE,Gramlich TL,Sigel JE,Richter JE,Goldblum JR. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol. 2000; 95: 33833387.
    Direct Link:
  • 23
    Chow W,Blaser MJ,Blot WJ. An inverse relationship between cagA strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998; 58: 588590.
  • 24
    Ye W,Held M,Lagergren J. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004; 96: 388396.
  • 25
    Gammon MD,Schoenberg JB,Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997; 89: 12771284.
  • 26
    Menke-Pluymers MB,Hop WC,Dees J,van Blankenstein M,Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett's) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer. 1993; 72: 11551158.
  • 27
    Lagergren J,Bergstrom R,Nyren O. Association between body mass and adenocarcinoma of the esophagus and cardia. Ann Int Med. 1999; 130: 883890.
  • 28
    Zhang ZF,Krutz RC,Sun M, et al. Adenocarcinomas of the esophagus and gastric cardia: medical condition, alcohol, and tobacco and socioeconomic factors. Cancer Epidemiol Biomarkers Prev. 1996; 5: 761768.
  • 29
    Kabat GC,Ng SK,Wynder EL. Tobacco, alcohol intake and diet in relationship to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control. 1993; 4: 123132.